Watson Pharmaceuticals confirmed it received a request for additional information from the Federal Trade Commission in connection with the drug maker's pending acquisition of Actavis Group.
Actavis has launched a generic drug for high blood pressure and chest pain, the company said.
Watson has announced its intention to acquire Actavis, the company said.
Watson Pharmaceuticals is buying Actavis Group for $5.9 billion, according to published reports.
Icelandic generic drug maker Actavis has appointed a new chief executive, Actavis said last week....